Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001207939 | SCV001379307 | uncertain significance | Pityriasis rubra pilaris; Psoriasis 2 | 2020-02-20 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. This variant has not been reported in the literature in individuals with CARD14-related conditions. This variant is present in population databases (rs758753920, ExAC 0.006%). This sequence change affects codon 612 of the CARD14 mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the CARD14 protein. |